Le medical plan to increase nearly 1 billion yuan to develop a large health industry 三山五岳何为峰

Dunlop medical preparation by nearly 1 billion yuan of industrial development issues in the health section of the flow of funds shares thousands of stocks the latest Rating Rating diagnosis simulation trading client Sina Level2:A shares of sina finance: App speed Kanpan live on-line blogger to tutor China securities network (reporter Chen Tian Yi) Dunlop medical bulletin, the quasi public offering the stock is not more than 27026767 shares, the total funds raised not more than 992 million yuan. Company shares resume trading on February 24th. In the investment project, 719 million yuan intends to acquire 40% equity project of Yue Pu pharmaceutical, and 273 million yuan will be put into the construction project of O2O network system and general cardiovascular network hospital. After the completion of the acquisition, Le Pu pharmaceutical will become a wholly owned subsidiary of the company, its net profit will be fully incorporated into the company consolidated statements. The company intends to use part of the funds raised into the general public cardiovascular network hospital and O2O marketing network system construction project. After the completion of the project, the construction of universal three level cardiovascular network hospital service system will be carried out to achieve barrier free medical care; the company will build the company’s online and offline three-dimensional marketing network, providing users with a more economical channel to buy the company’s products. The non-public offering will help the company continue to expand actively in the big health industry, expand the competitive advantage, and further achieve the company’s strategic objectives. Enter Sina Financial shares] discussion

乐普医疗拟定增近10亿元 发展大健康产业 热点栏目 资金流向 千股千评 个股诊断 最新评级 模拟交易 客户端 新浪财经Level2:A股极速看盘 新浪财经App:直播上线 博主一对一指导   中国证券网讯(记者 陈天弋)乐普医疗公告,拟非公开发行股票不超过27,026,767股,募集资金总额不超过9.92亿元。公司股票2月24日复牌。   募投项目中,7.19亿元拟收购乐普药业40%股权项目,2.73亿元拟投入乐普心血管网络医院及O2O营销网络体系建设项目。   本次收购完成后,乐普药业将成为公司的全资子公司,其实现的净利润将全部纳入公司合并报表。   公司本次拟使用部分募集资金投入乐普心血管网络医院及 O2O 营销网络体系建设项目。项目建成后,将构建乐普三级心血管网络医院服务体系,实现无障碍就医;公司将构建公司线上线下立体营销网络,为用户提供了购买公司产品更经济的新型通道。   本次非公开发行有利于公司继续在大健康产业积极扩张,扩大竞争优势,进一步实现公司的战略目标。 进入【新浪财经股吧】讨论相关的主题文章: